Tag Archives: A US Food and Drug Administration panel has voted to recommend that the government authorize Merck’s antiviral pill molnupiravir for high-risk covid-19 patients.

A US Food and Drug Administration panel has voted to recommend that the government authorize Merck’s antiviral pill molnupiravir for high-risk covid-19 patients.

The news: A US Food and Drug Administration panel has voted by 13 to 10 to recommend that the government authorize Merck’s antiviral pill for patients with early covid-19 who are at high risk for severe infection. The drug, called molnupiravir, has been shown to reduce the risk of hospitalization and death, although by less […]